-+ 0.00%
-+ 0.00%
-+ 0.00%
Dr. Reddy's wins Brazil approval for generic semaglutide injection
Share
Listen to the news
Dr. Reddy's wins Brazil approval for generic semaglutide injection
  • Brazil's ANVISA granted Dr. Reddy's marketing authorization for generic semaglutide injections for adults with insufficiently controlled type 2 diabetes.
  • A planned launch with Aché targets Brazil's semaglutide market for diabetes, estimated at USD 244.6 million.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Dr. Reddy's Laboratories Limited published the original content used to generate this news brief on November 05, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending